Epicured Acquires Chiyo
Epicured, a company focused on using food as medicine for chronic diseases, has acquired Chiyo, Inc. Chiyo is a company dedicated to advancing women's health through nutrition. The acquisition is intended to strengthen and scale Epicured's focus on women's healthcare.
- Chiyo was founded in 2021 by CEO Irene Liu and Chief Culinary Officer Jennifer Jolorte, focusing on maternal nutrition programs for fertility, pregnancy, and postpartum stages. - Prior to the acquisition, Chiyo had served over 100,000 meals and recently raised $3 million in a financing round, bringing its total funding to $3.4 million. - Epicured, co-founded by CEO Richard Bennett in 2016, initially focused on medically tailored meals for digestive health conditions such as IBS and Crohn's disease, partnering with health systems like Mount Sinai. - Epicured has since expanded its clinical nutrition platform to address diabetes, renal disease, and cardiovascular health, recently securing Medicaid contracts in New York to provide reimbursable meals. - The acquisition brings Chiyo's focus on women's health and Eastern food therapy into Epicured's broader platform of creating clinically-validated, condition-specific meals. - The deal is situated within the rapidly growing "food as medicine" market, which was valued at $25 billion in 2024 and is projected to reach $36.6 billion by 2034. - The global women's nutrition market was valued at over $50 billion in 2024, with North America holding the largest market share.
